Core Laboratories - CLB Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View CLB analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 1-year target prices for Core Laboratories' stock. Their CLB share price forecasts range from $20.00 to $26.00. On average, they predict the company's stock price to reach $21.83 in the next twelve months. This suggests a possible upside of 5.2% from the stock's current price.
View analysts price targets for CLB or view top-rated stocks among Wall Street analysts.

Core Laboratories' stock was trading at $20.27 on January 1st, 2023. Since then, CLB shares have increased by 2.4% and is now trading at $20.75.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our CLB earnings forecast.

Core Laboratories (NYSE:CLB) announced its quarterly earnings results on Thursday, February, 2nd. The oil and gas company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.19 by $0.01. The oil and gas company had revenue of $127.57 million for the quarter, compared to analysts' expectations of $130.12 million. Core Laboratories had a net margin of 3.97% and a trailing twelve-month return on equity of 15.98%. Core Laboratories's revenue was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.20 earnings per share.

Core Laboratories declared a quarterly dividend on Wednesday, February 1st. Stockholders of record on Monday, February 13th will be paid a dividend of $0.01 per share on Monday, March 6th. This represents a $0.04 annualized dividend and a dividend yield of 0.19%. The ex-dividend date is Friday, February 10th.
Read our dividend analysis for CLB.

ETFs with the largest weight of Core Laboratories (NYSE:CLB) stock in their portfolio include Cultivar ETF (CVAR), Invesco Dynamic Oil & Gas Services ETF (PXJ), Invesco S&P SmallCap Energy ETF (PSCE), SPDR S&P Oil & Gas Equipment & Services ETF (XES), iShares U.S. Oil Equipment & Services ETF (IEZ), VanEck Oil Services ETF (OIH), Direxion Daily Oil Services Bull 2X Shares (ONG) and Invesco S&P SmallCap 600 Equal Weight ETF (EWSC).

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.20%. The dividend payout ratio is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

Core Laboratories updated its first quarter earnings guidance on Wednesday, February, 1st. The company provided earnings per share guidance of $0.14-0.19 for the period, compared to the consensus earnings per share estimate of $0.18. The company issued revenue guidance of $125-129 million, compared to the consensus revenue estimate of $127.42 million.

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional investors include Ariel Investments LLC (20.92%), Fred Alger Management LLC (8.31%), Earnest Partners LLC (7.71%), Boston Trust Walden Corp (4.25%), Van ECK Associates Corp (2.15%) and Congress Asset Management Co. MA (1.54%).
View institutional ownership trends.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $20.75.

Core Laboratories (NYSE:CLB) has a market capitalization of $967.57 million and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.41 on an earnings per share basis.

The company employs 3,600 workers across the globe.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com.